Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2018, Article ID 3015854, 10 pages
https://doi.org/10.1155/2018/3015854
Clinical Study

Impact of Long-Acting Somatostatin Analogues on Glucose Metabolism in Acromegaly: A Hospital-Based Study

1Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai 200040, China
2Department of Endocrinology and Metabolism, Huashan Hospital, Fudan University, Shanghai 200040, China
3Department of Endocrinology and Metabolism, The Second People’s Hospital of Kashi, Xinjiang Uygur Autonomous Region 844000, China
4Department of Nuclear Medicine, Huashan Hospital, Fudan University, Shanghai 200040, China

Correspondence should be addressed to Xiaoyun Cao; moc.361@4952nuyoaixoac and Zhaoyun Zhang; nc.ude.naduf@gnahznuyoahz

Received 13 July 2017; Accepted 13 December 2017; Published 26 April 2018

Academic Editor: Mario Maggi

Copyright © 2018 Ming Shen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Ming Shen, Meng Wang, Wenqiang He, et al., “Impact of Long-Acting Somatostatin Analogues on Glucose Metabolism in Acromegaly: A Hospital-Based Study,” International Journal of Endocrinology, vol. 2018, Article ID 3015854, 10 pages, 2018. https://doi.org/10.1155/2018/3015854.